Clinical Trial Update: Effect of Low Doses of Hypoxia-inducible Factor- Prolyl Hydroxylase Enzyme Inhibitor Plus Iron in the Treatment of Anemia in Dialysis-dependent Chronic Kidney Disease Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating low doses of a hypoxia-inducible factor–prolyl hydroxylase inhibitor with iron for treating anemia in dialysis-dependent chro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia in Dialysis-dependent CKD Patients
• Chronic Kidney Disease

Snippet

Sponsor: Alexandria University | Conditions: Anemia in Dialysis-dependent CKD Patients | Phase 4 | Status: UNKNOWN